--- title: "12 Health Care Stocks Moving In Monday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/280159259.md" description: "In Monday's pre-market session, several health care stocks saw significant movement. Milestone Scientific (MLSS) shares surged 34.4% to $0.33, while BGM Group (BGM) rose 30.44% to $0.78. Zhengye Biotechnology (ZYBT) increased by 26.76% to $0.9, and Firefly Neuroscience (AIFF) gained 23.52% to $1.89. Apogee Therapeutics (APGE) and Insmed (INSM) also saw increases of 13.56% and 10.25%, respectively. Conversely, Valneva (VALN) dropped 36.8% to $6.52, followed by Impact BioMedical (IBO) down 23.04% to $0.6. Other notable losers included Onconetix (ONCO), Anika Therapeutics (ANIK), NeuroPace (NPCE), and CDT Equity (CDT)." datetime: "2026-03-23T12:05:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280159259.md) - [en](https://longbridge.com/en/news/280159259.md) - [zh-HK](https://longbridge.com/zh-HK/news/280159259.md) --- # 12 Health Care Stocks Moving In Monday's Pre-Market Session ### Gainers - **Milestone Scientific** (AMEX:MLSS) shares rose 34.4% to $0.33 during Monday's pre-market session. The market value of their outstanding shares is at $19.3 million. - **BGM Group** (NASDAQ:BGM) shares rose 30.44% to $0.78. The market value of their outstanding shares is at $120.3 million. - **Zhengye Biotechnology** (NASDAQ:ZYBT) stock increased by 26.76% to $0.9. The market value of their outstanding shares is at $33.6 million. - **Firefly Neuroscience** (NASDAQ:AIFF) shares rose 23.52% to $1.89. The market value of their outstanding shares is at $24.0 million. - **Apogee Therapeutics** (NASDAQ:APGE) shares moved upwards by 13.56% to $75.0. The market value of their outstanding shares is at $4.5 billion. - **Insmed** (NASDAQ:INSM) stock increased by 10.25% to $149.95. The company's market cap stands at $29.3 billion. ### Losers - **Valneva** (NASDAQ:VALN) stock decreased by 36.8% to $6.52 during Monday's pre-market session. The company's market cap stands at $896.5 million. As per the press release, Q4 earnings came out 3 days ago. - **Impact BioMedical** (AMEX:IBO) shares decreased by 23.04% to $0.6. The company's market cap stands at $84.1 million. - **Onconetix** (NASDAQ:ONCO) stock fell 17.75% to $0.51. - **Anika Therapeutics** (NASDAQ:ANIK) shares declined by 16.48% to $11.57. The company's market cap stands at $199.6 million. - **NeuroPace** (NASDAQ:NPCE) shares decreased by 15.39% to $11.0. The company's market cap stands at $433.0 million. - **CDT Equity** (NASDAQ:CDT) shares fell 10.65% to $0.43. The company's market cap stands at $1.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [PTH.US](https://longbridge.com/en/quote/PTH.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [AIFF.US](https://longbridge.com/en/quote/AIFF.US.md) - [MLSS.US](https://longbridge.com/en/quote/MLSS.US.md) - [APGE.US](https://longbridge.com/en/quote/APGE.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [INSM.US](https://longbridge.com/en/quote/INSM.US.md) - [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) ## Related News & Research - [Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus](https://longbridge.com/en/news/286727771.md) - [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md) - [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md) - [Harvest Portfolios Group Inc. Grows Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/287027124.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)